How Digital Genome Is Impacting The Research & Development On Chronic And Genetic Disease?
Digital Genome Market |
The Digital Genome is an extensive digital
collection of genetic material. It facilitates the study of complex genetic
systems and enables scientists to identify chronic diseases and disorders. This
technology is used in research on chronic diseases and genetic disorders, and
it facilitates custom queries and instant access to trait sequences. Digital
genomics is revolutionizing innovation-centered research and has already found
numerous applications. The growing awareness of genetic diseases has also
spurred the market growth.
The market is segmented by application,
product, and region. Segmentation by application includes sequencing chips,
RNA, and DNA. Sequencing and analyzer instruments are the most popular products
in the market. The increasing number of public and private investments in these
segments has driven the market's growth. The Key players in the market include
Illumina, Inc., Bio-Pharmaceutical Companies, and Perkin Elmer, Inc. These
companies are continuously introducing novel and advanced solution to meet the
growing demand worldwide.
The Digital
Genomics Market is fueled by the increasing awareness of genomic
diseases, technological advancements, and high-tech medical research. Recent
genomics research is aimed at identifying the areas of genome research that
will provide breakthroughs in biomedical fields. The National Human Genome
Research Institute, for example, recently announced its 2020 vision for
genomics research. It aims to identify areas of genomics that are
paradigm-shifting and will allow for new, targeted therapies.
The market is growing rapidly in North
America, largely due to the rising incidence of diseases such as cancer and the
increasing awareness of personalized medicine. Key players are investing in
novel products and regulatory approvals in order to tap into the region's
market potential. The technologies have also been favored by growing awareness
in developing countries.
The market is segmented by product. DNA/RNA
analysis comprises sequencing chips, sample prep instruments, and software.
Instruments for genome-level work hold the largest share of the digital
genomics market. These instruments are used primarily by pharmaceutical
companies in the advanced economies. The continuous innovation and development
of new technologies have also positively impacted the market. Recently, the
Becton-Dickinson-Company launched an automated next-generation sequencing
platform, the BD Rhapsody. The system features a fully automated
specimen-to-report workflow and delivers results in one day.
Artificial intelligence (AI) is expected to
further drive the global market. AI is a branch of artificial intelligence,
which involves using computer systems to solve tasks such as mapping genomes.
Machine learning algorithms are used to overcome genomic problems. Key players
in the market are focusing on collaboration and development of AI tools to grow
the market. They are also focused on AI research. This research activity is
fueled by the rapid development of AI technology. In short, the Digital Genome
market is thriving, thanks to AI. Inscripta has recently announced $150 million
in Series E funding to develop an automated benchtop instrument for
genome-scale engineering. This new system allows researchers to experiment
within cells and make thousands of edits in a single run. Inscripta has a
number of funding goals for the Digital Genome and has received numerous
patents.
Comments
Post a Comment